Axogen (AXGN) Share-based Compensation (2010 - 2026)
Axogen (AXGN) recorded quarterly Share-based Compensation of $6.8 million in Q1 2026, down 58.8% quarter-over-quarter from $16.6 million in Q4 2025, and up 135.24% on a YoY basis from $2.9 million in Q1 2025.
Axogen (AXGN) Share-based Compensation (2010 - 2026) Analysis & Trends
Axogen's Share-based Compensation history runs 17 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- In Q1 2026, Share-based Compensation rose 135.24% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $34.0 million (up 128.56% YoY), while the FY2025 annual figure was $30.1 million, up 89.31% from the prior year.
- Share-based Compensation was $6.8 million for Q1 2026 at Axogen, down from $16.6 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $16.6 million in Q4 2025 to a low of $1.3 million in Q4 2023.
- Historically, Share-based Compensation has averaged $4.9 million across 5 years, with a median of $4.2 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Share-based Compensation plunged 68.05% in 2023, then surged 440.02% in 2025.
- A 5-year view of Share-based Compensation shows it stood at $4.2 million in 2022, then slumped by 68.05% to $1.3 million in 2023, then jumped by 131.8% to $3.1 million in 2024, then soared by 440.02% to $16.6 million in 2025, then tumbled by 58.8% to $6.8 million in 2026.
- The last three Share-based Compensation figures came in at $6.8 million (Q1 2026), $16.6 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Axogen | 2.32 Bn | 2.22 Bn | 46.19 Mn | 6.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.84 Mn |
| Mar 31, 2026 | 6.84 Mn |
| Dec 31, 2025 | 16.61 Mn |
| Dec 31, 2025 | 16.61 Mn |
| Sep 30, 2025 | 5.42 Mn |
| Sep 30, 2025 | 5.42 Mn |
| Jun 30, 2025 | 5.17 Mn |
| Jun 30, 2025 | 5.17 Mn |
| Mar 31, 2025 | 2.91 Mn |
| Mar 31, 2025 | 2.91 Mn |
| Dec 31, 2024 | 3.08 Mn |
| Dec 31, 2024 | 3.08 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Jun 30, 2024 | 3.91 Mn |
| Mar 31, 2024 | 3.92 Mn |
| Mar 31, 2024 | 3.92 Mn |
| Dec 31, 2023 | 1.33 Mn |
| Dec 31, 2023 | 1.33 Mn |